Results 161 to 170 of about 68,976 (225)
Some of the next articles are maybe not open access.

Evaluation of thyroid nodules with technetium‐99m MIBI and technetium‐99m pertechnetate

Head & Neck, 2001
AbstractBackgroundMost thyroid centers use fine‐needle aspiration (FNA) and technetium‐99m pertechnetate for the preoperative assessment of thyroid nodules. This approach is sufficient in most cases other than follicular neoplasm, and follicular carcinoma is more common than papillary carcinoma in developing countries such as in our center.
M M, Sathekge   +4 more
openaire   +2 more sources

Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringes

European Journal of Nuclear Medicine and Molecular Imaging, 1998
Some groups have reported that adsorption of radiopharmaceuticals on disposable plastic syringes can reach levels of almost 50%. This high loss of radioactivity stimulated us to carry out similar studies. Our measurements were done in combination with patient studies. Therefore, we used 2-ml syringes, all of the same brand.
R, Bartosch, S, Granegger, H, Sinzinger
openaire   +2 more sources

Technetium 99m Sestamibi in Multiple Myeloma

Radiology, 2005
Editor: We read with great interest the excellent review on diagnostic imaging in multiple myeloma by Dr Angtuaco and colleagues in the April 2004 issue of Radiology (1). We would like to address just a few issues related to the use of technetium 99m (Tc) sestamibi.
PACE, Leonardo   +2 more
openaire   +6 more sources

Technetium-99m-labeled monoclonal antibodies: influence of technetium-99m binding sites.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994
A number of 99mTc-labeled monoclonal antibodies (Mabs) are being evaluated for diagnostic applications. Preparations are carried out using both direct and indirect (bifunctional chelating agent, BFCA) labeling procedures in which nonspecific 99mTc binding has been postulated.By using the ascorbic acid (AA) reduction mediated direct labeling procedure ...
E, John   +4 more
openaire   +2 more sources

Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile

European Journal of Nuclear Medicine, 1993
Thyroid imaging was performed using technetium-99m methoxyisobutylisonitrile and technetium-99m pertechnetate in 58 patients. The 99mTc-pertechnetate scans showed a total of 77 nodules: 60 cold, 13 hot and 4 of normal activity. There was no 99mTc-MIBI accumulation in 46.4% of 99mTc-pertechnetate cold nodules; 27 (45%) of these nodules showed 99mTc-MIBI
I, Földes, A, Lévay, G, Stotz
openaire   +2 more sources

Comparison of technetium-99m-MDP, technetium-99m-WBC and technetium-99m-HIG in musculoskeletal inflammation.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
This study compared three radionuclide techniques in distinguishing musculoskeletal infection from noninfectious inflammation.Thirty-five orthopedic patients with suspected musculoskeletal infection were examined using three radionuclide techniques in sequence: triphasic bone scintigraphy, 99mTc radioleukocytes (99mTc-WBC) scintigraphy and 99mTc human ...
F, Palermo   +6 more
openaire   +1 more source

Technetium-99m Radiopharmaceuticals

2010
The name technetium was derived by the scientist Mendeleyev from the Greek word technetos, meaning “artificial.” Technetium-99m was discovered in 1937 by Perrier and Segre in a sample of naturally occurring 98Mo irradiated by neutrons and deuterons. The first generator as a source for Tc-99m was introduced in 1957 at the Brookhaven National laboratory,
openaire   +1 more source

Technetium-99m nitride radiopharmaceuticals

Transition Metal Chemistry, 1997
Following the introduction of an efficient method for the preparation of technetium-99m complexes containing a terminal Tc-N multiple bond, under conditions suitable for nuclear medicine applications, new radiopharmaceuticals for heart and brain imaging have been discovered.
C. BOLZATI   +3 more
openaire   +3 more sources

Technetium-99m Pharmaceuticals

2007
I.- Drug Safety.- Technetium in Medicine.- Stannous Chloride in the Preparation of 99mTc Pharmaceuticals.- Quality Assurance of Radiopharmaceuticals.- Performance and Quality Control of the 99Mo/99mTc Generator.- Preparation of Technetium 99mTc Pharmaceuticals.- Lyophilization Technique for Preparing Radiopharmaceutical Kits.- Cellular Labeling with ...
openaire   +1 more source

Reproducibility of technetium-99m ethylenedicysteine clearance

European Journal of Nuclear Medicine and Molecular Imaging, 1999
It has been shown that technetium-99m ethylenedicysteine ((99m)Tc-EC) clearance displays a strong correlation with orthoiodohippurate clearance and that it is possible to estimate effective renal plasma flow from (99m)Tc-EC clearance. However, in routine practice, when monitoring renal function of patients by clearance determinations it is imperative ...
L, Kabasakal   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy